Capital Research Global Investors
MEDP icon

Capital Research Global Investors’s Medpace MEDP Stock Holding History

Capital Research Global Investors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-377,200
Closed -$11.3M – 437
2017
Q1 		$11.3M Buy
+377,200
New +$12.2M ﹤0.01% 403

Other funds holding MEDP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CLM
ClearBridge LLC (Maryland) Baltimore, Maryland $329M AUM 9.73% 1-Year Est. Return
GIP
Granite Investment Partners El Segundo, California $1.63B AUM 38.09% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Capital Research Global Investors's MEDP Position: Q2 2017 in Review

Capital Research Global Investors sold out of Medpace (MEDP) in Q2 2017, closing a stake of 377,200 shares — an estimated $11.3M sold.

Capital Research Global Investors first reported a position in MEDP in Q1 2017 and held it in 1 quarter. The position peaked at $11.3M in Q1 2017. 82 funds tracked by Wall St. Rank hold MEDP as of Q2 2017.

  • Capital Research Global Investors reported no remaining Medpace position as of Q2 2017 after selling out during the quarter.
  • Capital Research Global Investors sold 377,200 Medpace shares in Q2 2017, an estimated $11.3M.
  • Capital Research Global Investors first reported a position in Medpace in Q1 2017 and held it in 1 quarter.
  • Capital Research Global Investors's Medpace position peaked at $11.3M in Q1 2017.
  • 82 funds tracked by Wall St. Rank held Medpace as of Q2 2017.

Based on Capital Research Global Investors's 13F filing for Q2 2017, filed 14 Aug 2017.